- Home
- CELC vs VENU Comparison
CELC vs VENU Comparison
Compare CELC & VENU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- VENU
- Stock Information
- Founded
- CELC 2011
- VENU 2017
- Country
- CELC United States
- VENU United States
- Employees
- CELC N/A
- VENU N/A
- Industry
- CELC Medical Specialities
- VENU
- Sector
- CELC Health Care
- VENU
- Exchange
- CELC Nasdaq
- VENU NYSE
- Market Cap
- CELC 440.0M
- VENU 446.8M
- IPO Year
- CELC 2017
- VENU 2024
- Fundamental
- Price
- CELC $13.77
- VENU $14.11
- Analyst Decision
- CELC Strong Buy
- VENU
- Analyst Count
- CELC 6
- VENU 0
- Target Price
- CELC $30.67
- VENU N/A
- AVG Volume (30 Days)
- CELC 245.9K
- VENU 63.7K
- Earning Date
- CELC 08-13-2025
- VENU 08-21-2025
- Dividend Yield
- CELC N/A
- VENU N/A
- EPS Growth
- CELC N/A
- VENU N/A
- EPS
- CELC N/A
- VENU N/A
- Revenue
- CELC N/A
- VENU $17,393,799.00
- Revenue This Year
- CELC N/A
- VENU $91.00
- Revenue Next Year
- CELC N/A
- VENU $422.18
- P/E Ratio
- CELC N/A
- VENU N/A
- Revenue Growth
- CELC N/A
- VENU 20.48
- 52 Week Low
- CELC $7.58
- VENU $7.05
- 52 Week High
- CELC $19.77
- VENU $14.75
- Technical
- Relative Strength Index (RSI)
- CELC 59.12
- VENU N/A
- Support Level
- CELC $13.47
- VENU N/A
- Resistance Level
- CELC $14.57
- VENU N/A
- Average True Range (ATR)
- CELC 0.65
- VENU 0.00
- MACD
- CELC -0.04
- VENU 0.00
- Stochastic Oscillator
- CELC 36.65
- VENU 0.00
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About VENU VENU HOLDING CORPORATION
Venu Holding Corp is an entertainment and hospitality holding company based in Colorado Springs, Colorado. It designs, develops, owns, and operates up-scale music venues, outdoor amphitheaters, and full-service restaurants and bars where music, dining, and luxury experiences converge.